News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biothera's Imprime PGG(R) Improves Survival in KRAS Mutant Colorectal Cancer Patients


6/23/2011 9:24:03 AM

BARCELONA--(BUSINESS WIRE)--Biothera will present data from its Phase II clinical trial in stage IV KRAS mutant colorectal cancer at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer June 22-25.

Read at BioSpace.com


comments powered by Disqus
Biothera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES